Breakthroughs happen when the right elements combine—both in science and in business. As experts in organic chemistry, cardiovascular surgery, and strategic innovation, we bring the scientific precision and vision needed to push healthcare forward.

But we also know that the true magic happens with the right chemistry between a founding team and investors. If you’re looking for a partner where expertise meets synergy, let’s create something transformative together.

The MediGuide advantage

We’re deep tech entrepreneurs from Ljubljana, Slovenia (EU), with interdisciplinary expertise spanning organic chemistry, cardiovascular surgery, marketing, and innovation management. Our team holds 6 approved patents and has successfully launched two startups, bringing advanced technologies to market.

Building on a strong foundation in academic research and value-based healthcare, we focus on solving critical challenges in healthcare. We are committed to enhancing surgical outcomes and improving patient care.

Rapid market growth with 14.8% CAGR

The global surgical simulation market was valued at $519 million in 2023, with a projected CAGR of 14.8%, reaching $1.5 billion by 2030. This remarkable growth highlights the increasing demand for innovative solutions in surgical planning and healthcare efficiency. 

This is where MediGuide creates a unique business opportunity by addressing a critical gap that has hindered the widespread adoption of 3D printing in healthcare. The potential to save lives, improve quality of life, and enhance patient engagement further underscores our focus, driving our commitment to transformative patient care solutions.

We are advancing to TRL 6-7 by Q1 2025

Our active collaborations will enable us to advance our solutions to TRL 6-7, focusing on refinement through joint pilot and research programs with leading hospitals and medical universities in Slovenia. We expect to reach this milestone by the end of Q1 2025. 

These validation efforts have already demonstrated significant improvements in surgical training and enhanced patient understanding, reinforcing the clinical and educational impact of our solutions. The next key steps include obtaining patents and securing a strategic licensing agreement.

Join us in shaping the future of healthcare